Navigation Links
Tarsa Therapeutics Presents Positive Efficacy and Safety Data Comparing Its Oral Calcitonin to Nasal Calcitonin and Placebo in Phase III Osteoporosis Treatment Trial
Date:9/19/2011

for osteoporosis patients and their physicians."

According to the International Osteoporosis Foundation, studies indicate that up to half of osteoporosis patients stop their treatment after just one year.  In one study, two-thirds of osteoporosis patients said their medication interfered with their lives in some way and over 20% of the women who missed or stopped their treatment said it was due to side effects.

"The encouraging efficacy and safety data presented at the ASBMR meeting, including data showing that OSTORA demonstrated superior efficacy to nasal calcitonin, reinforces our view that OSTORA has the potential to address an unmet need in current therapy," noted David Krause, MD, Chief Medical Officer of Tarsa.  "Data suggest that approximately two million women in the U.S. alone have discontinued osteoporosis treatment for various reasons, which include poor tolerance or the perceived risk of adverse effects, leaving them more vulnerable to potentially disabling fractures.  Reports from the field suggest many other newly diagnosed osteoporosis patients have not started drug treatment as a result of safety concerns.  The data presented today indicate that once-daily OSTORA may have the potential to provide an effective, safe and convenient new option for these millions of women and their physicians."

Calcitonin is approved for the treatment of postmenopausal osteoporosis, but its use has been limited by the fact that it is currently available only in intranasal and injectable forms.  Prior clinical studies show that Tarsa's oral calcitonin tablet delivers calcitonin effectively and reduces blood levels of bone resorption biomarkers.

"We view the new OSTORA data presented today as very promising news for osteoporosis patients and their physicians seeking additional treatment options," said David Brand, President and CEO of Tarsa.  "We look forward to filing a New Drug Application for OSTORA with the F
'/>"/>

SOURCE Tarsa Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Tarsa Therapeutics Reports Positive Top-Line Results From Pivotal Phase III ORACAL Trial of its Oral Calcitonin in Treatment of Postmenopausal Osteoporosis
2. Tarsa Therapeutics Completes Phase III Trial of its Oral Calcitonin for Treatment of Postmenopausal Osteoporosis and Initiates Phase II Trial in Osteoporosis Prevention
3. Silence Therapeutics Announces Issuance of Japanese Patent for Screening Therapeutics Against Key Pathway Associated with Cancer and Other Diseases
4. Echo Therapeutics Receives Registered Trademarks for Symphony® and Prelude®
5. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at the UBS 2011 Global Life Sciences Conference in New York City
6. ViroPharma and Halozyme Therapeutics Announce Initiation of Phase 2 Evaluation of Subcutaneous Delivery of Cinryze® (C1 Esterase Inhibitor [Human]) with Hyaluronidase (rHuPH20)
7. Rare Disease Therapeutics, Inc. Selects Accredo Health Group to Distribute Anascorp® for the Treatment of Centruroides Scorpion Sting Envenomation
8. Silence Therapeutics and InteRNA Technologies Sign Collaboration to Develop Novel microRNA Therapeutics
9. Nile Therapeutics to Present at Rodman & Renshaw Global Investment Conference
10. Regulus Therapeutics to Present New Advancements in microRNA Therapeutics for Treatment of Metabolic Diseases and Cancer
11. Global Sepsis Therapeutics Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... , May 27, 2015 ... announced the addition of the  "US Cancer ... their offering.       (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ... into to two broad categories of prophylactic ... cancer vaccines belong to both of these ...
(Date:5/27/2015)... 26, 2015 Research and Markets( http://www.researchandmarkets.com/research/ljsxt8/asia_pacific ) has ... Ray Devices Market - Growth, Trends And Forecasts (2014 - ... Asia Pacific market for Portable X-Ray ... 2014 to 2020 X-Ray is a form of ... the body, especially bones. The need of point of care ...
(Date:5/27/2015)... Research and Markets( http://www.researchandmarkets.com/research/nt9zlx/asia_pacific ) has announced ... - Growth, Trends And Forecasts (2014 - 2019)" ... a detailed type of imaging that customs a low-dose ... a mammogram, is used to support in the early ... x-ray (radiograph) is a noninvasive medical test that helps ...
Breaking Medicine Technology:US Cancer Vaccine Market Outlook 2020 2US Cancer Vaccine Market Outlook 2020 3Asia Pacific Portable X Ray Devices Market 2015 - Trends And Forecasts to 2019 2Asia Pacific Mammography Market Trends and Forecasts 2015-2019 2
(Date:5/27/2015)... (PRWEB) May 27, 2015 Genius Monkey ... their advanced programmatic marketing technology, they have boosted sales ... support on a regional level for seven Utah-based dealers. ... was through television and radio media. In 2014 the ... the help of Genius Monkey , shifted their ...
(Date:5/27/2015)... With InnerVoice Communication App you will ... is not only heard but seen -- by a photograph ... image. This award-winning and affordable app takes full advantage of ... InnerVoice Sender app in conjunction with InnerVoice Communication ... remotely for no additional cost. , InnerVoice Sender ...
(Date:5/27/2015)... 27, 2015 With a prevalently high ... conducted during the "ACA - Controlling the Chaos" webinar ... are currently in the process of researching ACA ... confidently prepared for the reporting mandates. , According to ... webinar, those who are currently vetting ACA reporting solutions ...
(Date:5/27/2015)... http://www.smarterskindermatology.com , is taking skin care customization to a ... for patients to find skin care products that work specifically ... a cosmetic dermatologist based in New York and is the ... DNA test uses 16 genetic markers to evaluate the following ... Firmness and elasticity , 2. Glycation , 3. Sun damage ...
(Date:5/27/2015)... 27, 2015 Decorview , a ... is offering free design advice to homeowners looking to ... , “Light pollution caused by streetlights, outdoor signs, full ... night’s sleep, said Kim Rush, VP of sales and ... across North America with recently installed LED streetlights– the ...
Breaking Medicine News(10 mins):Health News:Genius Monkey Boosts Utah Honda Dealers Website Traffic 142% 2Health News:Newly Released: InnerVoice Sender App Ups the Ante in Communication Technology for Autism with Remote Prompting 2Health News:Newly Released: InnerVoice Sender App Ups the Ante in Communication Technology for Autism with Remote Prompting 3Health News:Newly Released: InnerVoice Sender App Ups the Ante in Communication Technology for Autism with Remote Prompting 4Health News:Employers are On Track for ACA Reporting According to Businessolver Poll 2Health News:SmarterSkin Dermatology is Now Offering Skin DNA Analysis 2Health News:Decorview Helps Homeowners Combat Light Pollution 2
... students to surgeons, anyone who has pulled an all-nighter knows ... trouble focusing, a fuzzy memory and other cognitive impairments. ... brain and the neurochemical basis for sleep deprivation,s effects on ... Penn,s School of Arts and Sciences and director of the ...
... By Jenifer Goodwin HealthDay Reporter , TUESDAY, ... Drug Administration advisory committees plan to meet Tuesday and ... instructions on the labels of medicines containing acetaminophen need ... of 2 against possible liver failure and even death. ...
... By Amanda Gardner HealthDay Reporter , TUESDAY, ... 30 percent of their hospital emergency rooms in the past ... than 35 percent, new research shows. And the closures ... who are poor, publicly insured or uninsured -- people without ...
... 17, 2011 -- In New York City, the prevalence ... anywhere from 3% to 19%, and children growing up ... fold differences in risk for having asthma. In ... localized differences, researchers at Columbia University,s Mailman School of ...
... A study conducted at the University of Arizona College ... clinical decision support software systems the computer programs ... medication problems correctly identified potentially dangerous drug-drug interactions. ... Arizona. Members of the research team tested the pharmacy ...
... News) -- A gene variation that causes faulty cholesterol regulation ... and may be a reason why some women can,t get ... at more than 200 infertile women who were undergoing in ... of the scavenger receptor class B type 1 (SCARB1) gene. ...
Cached Medicine News:Health News:Penn researchers identify the roots of memory impairment resulting from sleep deprivation 2Health News:Penn researchers identify the roots of memory impairment resulting from sleep deprivation 3Health News:FDA Panels to Weigh Dosing Labels for Kids' OTC Fever Relievers 2Health News:FDA Panels to Weigh Dosing Labels for Kids' OTC Fever Relievers 3Health News:FDA Panels to Weigh Dosing Labels for Kids' OTC Fever Relievers 4Health News:Almost 30% of Urban ERs Closed During Past Two Decades: Study 2Health News:Almost 30% of Urban ERs Closed During Past Two Decades: Study 3Health News:Cockroach allergens in homes associated with prevalence of childhood asthma in some neighborhoods 2Health News:Gene Variation May Explain Some Female Infertility Cases 2
MiniCycler thermal cycler with Hot Bonnet heated lid, holds 16x0.5ml tubes...
Dual-bay Dyad thermal cycler chassis, does not include the Alpha units (requires 2)...
... Sprint with 24-well x 0.2ml sub-ambient block ... tube thermistor) Heating rates: up to 3C/second; ... 4-99C; Excellent uniformity: better than 0.5C within ... use programming: directory program storage of up ...
... an inexpensive personal or mini thermal cycler, and ... with a small footprint, it can be easily ... desk. , The Gene Cycler thermal cycler meets ... access to a large laboratory thermal cycler, or ...
Medicine Products: